We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
+6.8%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$20.4B
AUM Growth
+$1.11B
(+5.8%)
Cap. Flow
+$100M
Cap. Flow
% of AUM
0.49%
Top 10 Holdings %
Top 10 Hldgs %
18.19%
Holding
3,316
New
217
Increased
1,367
Reduced
1,468
Closed
167
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$43.9M |
| 2 |
JPMorgan BetaBuilders US Aggregate Bond ETF
BBAG
|
+$31.7M |
| 3 |
iShares Core S&P US Value ETF
IUSV
|
+$27.7M |
| 4 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$26.5M |
| 5 |
First Trust Enhanced Short Maturity ETF
FTSM
|
+$22.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$44.6M |
| 2 |
Vanguard Total International Bond ETF
BNDX
|
+$30.3M |
| 3 |
Vanguard Dividend Appreciation ETF
VIG
|
+$30.3M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$30.2M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$28.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.45% |
| 2 | Financials | 4.68% |
| 3 | Healthcare | 4.07% |
| 4 | Consumer Discretionary | 3.92% |
| 5 | Industrials | 2.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2476
Metallus
MTUS
$892M
| $306K | ﹤0.01% |
16,666
-5,103
| -23% | -$95.3K |
|
2477
Brunswick
BC
$5.29B
| $305K | ﹤0.01% |
3,725
+501
| +16% | +$41.4K |
|
2478
DMC Global
BOOM
$153M
| $305K | ﹤0.01% |
+13,898
| New | +$318K |
|
2479
Southside Bancshares
SBSI
$984M
| $305K | ﹤0.01% |
9,192
-177
| -2% | -$6.46K |
|
|
EIM
2480
Eaton Vance Municipal Bond Fund
EIM
$500M
| $304K | ﹤0.01% |
29,272
-157
| -0.5% | -$1.61K |
|
2481
Fastly Inc
FSLY
$4.78B
| $304K | ﹤0.01% |
17,107
+531
| +3% | +$6.75K |
|
2482
Dimensional International High Profitability ETF
DIHP
$6.59B
| $303K | ﹤0.01% |
+12,535
| New | +$295K |
|
2483
Innovator Emerging Markets Power Buffer ETF April
EAPR
$102M
| $303K | ﹤0.01% |
12,409
+200
| +2% | +$4.81K |
|
2484
HSBC
HSBC
$358B
| $303K | ﹤0.01% |
8,887
-2,664
| -23% | -$95.6K |
|
2485
Ionis Pharmaceuticals
IONS
$9.28B
| $303K | ﹤0.01% |
8,474
-1,081
| -11% | -$40.6K |
|
2486
Global Ship Lease
GSL
$1.49B
| $302K | ﹤0.01% |
16,122
-6,388
| -28% | -$119K |
|
|
LTC
2487
LTC Properties
LTC
$2.1B
| $301K | ﹤0.01% |
8,567
-92
| -1% | -$3.31K |
|
2488
SkinHealth Systems
SKIN
$85.9M
| $301K | ﹤0.01% |
23,852
-1,270
| -5% | -$14.7K |
|
2489
Belden
BDC
$5.36B
| $300K | ﹤0.01% |
+3,456
| New | +$287K |
|
2490
Roundhill Sports Betting & iGaming ETF
BETZ
$50M
| $300K | ﹤0.01% |
18,484
-574
| -3% | -$9.15K |
|
2491
Innovator International Developed Power Buffer ETF January
IJAN
$264M
| $300K | ﹤0.01% |
10,546
+2,615
| +33% | +$72.9K |
|
2492
ITT
ITT
$19.4B
| $300K | ﹤0.01% |
3,477
+79
| +2% | +$6.94K |
|
|
WWE
2493
DELISTED
World Wrestling Entertainment
WWE
| $300K | ﹤0.01% |
3,291
-210
| -6% | -$18K |
|
2494
Galectin Therapeutics
GALT
$356M
| $299K | ﹤0.01% |
142,403
-9,168
| -6% | -$14.8K |
|
2495
BlackRock TCP Capital
TCPC
$353M
| $299K | ﹤0.01% |
29,054
-2,680
| -8% | -$32.4K |
|
2496
iShares MSCI China A ETF
CNYA
$207M
| $298K | ﹤0.01% |
+9,126
| New | +$303K |
|
2497
Innovator US Equity Ultra Buffer ETF March
UMAR
$196M
| $298K | ﹤0.01% |
10,380
+1,302
| +14% | +$36.8K |
|
|
NAGE
2498
Niagen Bioscience
NAGE
$241M
| $298K | ﹤0.01% |
194,558
+68,000
| +54% | +$121K |
|
2499
ONE Gas
OGS
$5.09B
| $297K | ﹤0.01% |
3,744
-277
| -7% | -$22K |
|
2500
Resources Connection
RGP
$145M
| $297K | ﹤0.01% |
17,407
+5,390
| +45% | +$94.6K |
|
Similar funds
LP
HF
Cambridge Investment Research Advisors's Q1 2023 Portfolio in Review
As of Q1 2023, Cambridge Investment Research Advisors held 3,316 positions worth $20.4B, up 5.8% from $19.3B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Cambridge Investment Research Advisors's Q1 2023 filing shows 217 new, 1,367 increased, 1,468 reduced and 167 closed positions. Its largest new stake was State Street SPDR Bloomberg International Treasury Bond ETF: 735,671 shares worth $17M. The largest sale was iShares 0-1 Year Treasury Bond ETF, an estimated $44.6M.
By sector, the portfolio is most concentrated in Technology at 9.4% of assets, up from 8% a quarter earlier, followed by Financials and Healthcare.
- Cambridge Investment Research Advisors's largest Q1 2023 buy was State Street SPDR Bloomberg International Treasury Bond ETF: 735,671 shares worth $17M.
- Cambridge Investment Research Advisors added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q1 2023, an estimated $43.9M increase.
- Cambridge Investment Research Advisors's biggest Q1 2023 reduction was iShares 0-1 Year Treasury Bond ETF, cutting an estimated $44.6M.
- Cambridge Investment Research Advisors fully exited ProShares Short Russell2000 in Q1 2023, selling an estimated $4.61M.
- Cambridge Investment Research Advisors's ten largest holdings make up 18% of its $20.4B portfolio in Q1 2023.
- Cambridge Investment Research Advisors opened 217 new positions and closed 167 in Q1 2023.
- Cambridge Investment Research Advisors's portfolio value rose 5.8% quarter-over-quarter to $20.4B.
Based on Cambridge Investment Research Advisors's 13F filing for Q1 2023, filed 11 May 2023.